Events & Presentations

Events & Presentations

August 3, 2020 CMSC

Glatiramer Acetate (GA) Produced by Mapi Pharma is Equivalent to Commercially Available GA Preparations

Read more
April 25, 2020 AAN 2020

Glatiramer Acetate Depot (extended-release) phase IIa study in patients with relapsing remitting Multiple Sclerosis: safety, tolerability and efficacy (No Evidence of Disease Activity) subpopulation three-years analysis

Read more
April 25, 2020 AAN 2020

Glatiramer Acetate Depot (extended-release) phase IIa study in patients with primary progressive Multiple Sclerosis: safety and efficacy snapshot

Read more
September 13, 2019 ECTRIMS 2019

Glatiramer acetate depot (extended-release) accumulated safety data in relapsing remitting multiple sclerosis & primary progressive multiple sclerosis phase IIa studies

Read more
September 13, 2019 ECTRIMS 2019

Glatiramer acetate depot (extended-release) Phase IIa study in patients with relapsing remitting multiple sclerosis: safety, tolerability and efficacy (no evidence of disease activity) subpopulation three-years analysis

Read more
May 30, 2019 CMSC 2019

Measurement of Anti-Glatiramer Acetate (GA) Antibodies in the Serum of RRMS Subjects Treated with GA Depot for 24 Months

Read more
May 7, 2019 AAN 2019

Glatiramer Acetate Depot (Extended-Release) Phase IIa Study in Patients with Relapsing Remitting Multiple Sclerosis: Safety, Tolerability and Efficacy (No Evidence of Disease Activity) Two-Years Analysis

Read more
2019

Mapi Pharma – Corporate Presentation 2019

Carlo Tornatore, MD, is Professor and Chairman of Neurology at Georgetown University Medical Center as well as Director of the Multiple Sclerosis Patient Centered Specialty Practice at Medstar Georgetown University Hospital in Washington, DC. Read more
October 12, 2018 ECTRIMS 2018

Glatiramer Acetate Depot (Extended-Release) phase IIa study in patients with relapsing remitting multiple sclerosis: safety, tolerability and efficacy (no evidence of disease activity) two-year analysis

Carlo Tornatore, MD, is Professor and Chairman of Neurology at Georgetown University Medical Center as well as Director of the Multiple Sclerosis Patient Centered Specialty Practice at Medstar Georgetown University Hospital in Washington, DC. Read more
April 27, 2018 AAN 2018

Glatiramer Acetate Depot (extended-release) Phase IIa one-year study in patients with Relapsing-remitting Multiple Sclerosis: Safety, tolerability and efficacy – NEDA Analysis

Carlo Tornatore, MD, is Professor and Chairman of Neurology at Georgetown University Medical Center as well as Director of the Multiple Sclerosis Patient Centered Specialty Practice at Medstar Georgetown University Hospital in Washington, DC. Read more
February 13, 2018 New York

KOL Webcast: Dr. Carlo Tornatore

Carlo Tornatore, MD, is Professor and Chairman of Neurology at Georgetown University Medical Center as well as Director of the Multiple Sclerosis Patient Centered Specialty Practice at Medstar Georgetown University Hospital in Washington, DC. Read more
October 27, 2017 ECTRIMS 2017

Glatiramer acetate depot (extended-release) phase IIa one-year study in patients with relapsing remitting multiple sclerosis: safety, tolerability and efficacy (no evidence of disease activity) analysis

Read more
October 27, 2017 ECTRIMS 2017

Glatiramer Acetate Depot (extended-release) Phase IIA study in patients with Relapsing Remitting Multiple Sclerosis: Six months’ interim analysis

Read more
April 20, 2016 AAN 2016

Pre-Clinical Studies and Evaluation of Treatment Need of Glatiramer Acetate Depot (Long Acting Injection)

Read more
October 8, 2015 ECTRIMS 2015

Pre-clinical studies and evaluation of treatment need of glatiramer acetate depot

Read more
June 11-14, 2015 ISNI 2015

Glatiramer Acetate Depot: Towards Clinical Application: oral presentation

Read more